Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

Disease Sites:

Head/Neck, Phase I

Staging:

Phase I

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Rosenthal, Eben

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

04-17-2025

Trial Type:

Treatment

Protocol ID:

VICCHNP24602

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available